Receives High Court order on 27 January 2016
Hester Biosciences announced that the Scheme of Arrangement in the nature of Amalgamation of Diavetra Lifesciences, Gujarat Agrofarm and Hester Biosciences (Mauritius) with Hester Biosciences and De-merger and Transfer of Trading undertaking of Innoves Animal Health into Hester Biosciences filed under Section 391 - 394 and other applicable provisions, if any, of the Companies Act 1956, the Companies Act 2013 and Mauritius Companies Act, 2001 has been sanctioned by the Hon'ble High Court of Gujarat.The certified copy of the said order is received by the Company on 27 January 2016 and pursuant to the aforesaid order, the Company is in the process of making the requisite filing with the Registrar of Companies, Gujarat at Ahmedabad. Further, the Company shall also be complying with document filing requirements in accordance with the SEBI guidelines.
Powered by Capital Market - Live News
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
